Interleukin-33/ST2 system attenuates aldosterone-induced adipogenesis and inflammation.
about
Mineralocorticoid receptor antagonists in patients with heart failure: current experience and future perspectivesGalectin-3 inhibition prevents adipose tissue remodelling in obesity.IL-25 stimulates M2 macrophage polarization and thereby promotes mitochondrial respiratory capacity and lipolysis in adipose tissues against obesity.Soluble ST2 in end-stage heart failure, before and after support with a left ventricular assist device.
P2860
Interleukin-33/ST2 system attenuates aldosterone-induced adipogenesis and inflammation.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Interleukin-33/ST2 system attenuates aldosterone-induced adipogenesis and inflammation.
@en
Interleukin-33/ST2 system attenuates aldosterone-induced adipogenesis and inflammation.
@nl
type
label
Interleukin-33/ST2 system attenuates aldosterone-induced adipogenesis and inflammation.
@en
Interleukin-33/ST2 system attenuates aldosterone-induced adipogenesis and inflammation.
@nl
prefLabel
Interleukin-33/ST2 system attenuates aldosterone-induced adipogenesis and inflammation.
@en
Interleukin-33/ST2 system attenuates aldosterone-induced adipogenesis and inflammation.
@nl
P2093
P50
P1476
Interleukin-33/ST2 system attenuates aldosterone-induced adipogenesis and inflammation.
@en
P2093
Amaya Fernández-Celis
Ana M Briones
Céline Leroy
Elodie Rousseau
Laurent Calvier
María Miana
Natalia López-Andrés
Raquel Jurado-López
Virginia Álvarez
P356
10.1016/J.MCE.2015.04.007
P577
2015-04-17T00:00:00Z